TVAR live edited broadcasts are safe.

Original title: The impact of live transmition on patients outcomes during transcatheter aortic valve replacement: Results fron the VERITAS study. Reference: Ron Waskman, et al. Cardiovascular Revascularization Medicine 2014;15:63-68

 

With the advancement of medical technology and the great development of telecommunications, performing live or edited cases has become a common occurrence in medical education, but one of the points of discussion was always the safety of these procedures. This is a multicentre, retrospective observational case-control study. The endpoint of this analysis was the safety of patients receiving percutaneous aortic valve replacement (TVAR) during live broadcasts. Valves used were, for femoral access CoreValve and for femoral or apical access, Edwards SAPIEN. Patients receiving TVAR during a live broadcast were compared with a control group using the following criteria; STS ± 2 points, day of the procedure ±4 weeks, same first surgeon and the same access resulting one control group of 46 patients and live stream group of 46 patients. The safety endpoint was evaluated by the rate of major complications: hospital death, stroke, tamponade, embolization, coronary obstruction, renal failure requiring dialysis and need for pacemaker.

No clinical or echocardiographic results from the group live stream versus the control group were observed. The total duration of the procedure was higher in the live broadcast group (129 ± 49 versus 100 ± 42 minutes p = 0.007) but no difference in fluoroscopy time, number of surgeons, intra procedural complications, stay in coronary unit or hospital. The presence of moderate or severe aortic regurgitation was 4.7 % in the live stream group and 9.5 % in the control group without reaching statistical significance. There were no differences in the safety endpoint, death (2.2 % in each group), conversion to surgery, vascular complications, bleeding, arrhythmias, need for pacemaker or dialysis infections.

Conclusion

These data provide support that procedures of percutaneous aortic valve replacement live broadcast for congress made

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...